OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HMAA55

HMA Agro Industries Ltd

Food Retail & DistributionVerified

HMA Agro Industries Ltd exhibits a capital structure with a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. The company holds INR 801.57 million in cash and equivalents, but this is offset by INR 4,920.47 million in long-term debt, resulting in a net cash position that is negative after subtracting total debt. The liquidity risk is assessed as medium, with a current ratio of 1.45, suggesting the company has sufficient short-term assets to cover its short-term liabilities, but with limited buffer. Profitability metrics show a weak performance, with a return on equity (ROE) of 0.13% and a return on assets (ROA) of 0.06%. These figures are below the typical thresholds for healthy returns in the Food Retail & Distribution industry, indicating that the company is not effectively utilizing its equity and assets to generate profit. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The absence of segment-specific revenue breakdowns in the latest financials limits the ability to assess the performance of individual business lines. The company's growth trajectory is uncertain, with no disclosed revenue growth in the latest financial period. The operating cash flow is negative at INR -1,658.06 million, and capital expenditures are INR -380.14 million, suggesting ongoing investment in infrastructure or expansion. However, the net income of INR 9.22 million indicates that the company is still generating modest profits despite these outflows. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth opportunities. No significant dilution sources are identified in the latest filings, and the dilution risk is assessed as low. Recent events include the latest financial filing, which discloses the company's financial position as of the most recent reporting period. No significant earnings call transcripts or regulatory filings have been identified that would indicate major strategic shifts or operational changes.

30-day price · HMAA+0.42 (+1.8%)
Low$21.25High$27.00Close$23.89As of12 May, 00:00 UTC
Profile
CompanyHMA Agro Industries Ltd
TickerHMAA.NS
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. HMA Agro Industries Ltd operates in the Food Retail & Distribution industry, primarily engaged in the retail and distribution of food and drug products, generating revenue through sales to consumers and businesses.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, within the Food & Drug Retailing business sector, with a high confidence level of 0.92.

HMA Agro Industries Ltd exhibits a capital structure with a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. The company holds INR 801.57 million in cash and equivalents, but this is offset by INR 4,920.47 million in long-term debt, resulting in a net cash position that is negative after subtracting total debt. The liquidity risk is assessed as medium, with a current ratio of 1.45, suggesting the company has sufficient short-term assets to cover its short-term liabilities, but with limited buffer. Profitability metrics show a weak performance, with a return on equity (ROE) of 0.13% and a return on assets (ROA) of 0.06%. These figures are below the typical thresholds for healthy returns in the Food Retail & Distribution industry, indicating that the company is not effectively utilizing its equity and assets to generate profit. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The absence of segment-specific revenue breakdowns in the latest financials limits the ability to assess the performance of individual business lines. The company's growth trajectory is uncertain, with no disclosed revenue growth in the latest financial period. The operating cash flow is negative at INR -1,658.06 million, and capital expenditures are INR -380.14 million, suggesting ongoing investment in infrastructure or expansion. However, the net income of INR 9.22 million indicates that the company is still generating modest profits despite these outflows. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth opportunities. No significant dilution sources are identified in the latest filings, and the dilution risk is assessed as low. Recent events include the latest financial filing, which discloses the company's financial position as of the most recent reporting period. No significant earnings call transcripts or regulatory filings have been identified that would indicate major strategic shifts or operational changes.
Key takeaways
  • HMA Agro Industries Ltd has a moderate debt-to-equity ratio of 0.69, but its net cash position is negative after subtracting total debt.
  • The company's ROE of 0.13% and ROA of 0.06% are below industry norms, indicating weak profitability.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • The company is generating modest net income despite negative operating cash flow and capital expenditures.
  • Liquidity risk is assessed as medium, and dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$13.90B
Gross profit$1.67B
Operating income-$25.3M
Net income$9.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.66B
CapEx-$380.1M
Free cash flow
Total assets$14.39B
Total liabilities$7.22B
Total equity$7.17B
Cash & equivalents$801.6M
Long-term debt$4.92B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$17.07B$898.5M$716.0M$624.2M
FY-3$30.83B$1.12B$1.15B$451.8M
FY-2$32.09B$1.50B$1.20B$227.3M
FY-1$48.13B$1.05B$1.01B$823.2M
FY0$51.33B$742.6M$867.8M$853.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$5.72B$2.59B$85.3M
FY-3$8.56B$3.74B$100.0k
FY-2$9.99B$4.74B$250.0k
FY-1$14.39B$7.17B$801.6M
FY0$17.10B$7.89B$650.2M
PeriodOCFCapExFCFSBC
FY-4$749.7M-$174.8M$624.2M
FY-3-$319.6M-$819.7M$451.8M
FY-2$1.36B-$1.09B$227.3M
FY-1-$1.66B-$380.1M$823.2M
FY0$1.24B-$218.0M$853.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$13.90B-$25.3M$9.2M
FQ-6$7.13B-$4.9M$13.3M
FQ-5$14.66B$494.9M$519.4M
FQ-4$14.55B$227.8M$202.9M
FQ-3$15.00B-$41.6M$132.2M
FQ-2$11.23B-$21.8M$8.1M
FQ-1$21.55B$873.3M$897.6M
FQ0$20.59B$564.5M$662.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$14.39B$7.17B$801.6M
FQ-6
FQ-5$19.69B$7.55B$1.28B
FQ-4
FQ-3$17.10B$7.89B$650.2M
FQ-2
FQ-1$17.68B$8.64B$905.7M
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$1.66B-$380.1M
FQ-6
FQ-5-$37.8M-$96.3M
FQ-4
FQ-3$1.24B-$218.0M
FQ-2
FQ-1$314.1M-$220.1M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.17B
Net cash-$4.12B
Current ratio1.4
Debt/Equity0.7
ROA0.1%
ROE0.1%
Cash conversion-179.8%
CapEx/Revenue-2.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricHMAAActivity
Op margin-0.2%3.1% medp25 1.2% · p75 6.8%bottom quartile
Net margin0.1%2.0% medp25 0.7% · p75 4.1%bottom quartile
Gross margin12.0%26.1% medp25 17.2% · p75 32.0%bottom quartile
CapEx / revenue-2.7%-2.5% medp25 -4.6% · p75 -1.4%below median
Debt / equity69.0%56.0% medp25 16.8% · p75 121.1%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:18 UTC#e7eda515
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 03:23 UTCJob: 4e1983d8